Vertex Pharmaceuticals (VRTX)

Change in Working Capital

-$115.00M

Quarterly · Period ending: · USD

VRTX logo

VRTX Change in Working Capital

Latest reported-$115.00M
VRTX Quarterly Change in Working Capital ($100.00K → -$115.00M)
High-resolution chart · PNG

VRTX change in working capital history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Change in Working Capital — Quarterly (USD)
Period endingChange in Working Capital (USD)
-115,000,000
244,700,000
-947,800,000
149,600,000
-132,400,000
-268,500,000
-560,200,000
157,500,000
-241,400,000
129,300,000
-838,900,000
188,900,000
245,400,000
138,900,000
-90,900,000
80,800,000
383,700,000
-32,800,000
134,684,000
-91,565,000
-164,458,000
16,139,000
-307,161,000
95,872,000
179,260,000
-22,425,000
-222,016,000
135,042,000
83,094,000
-62,221,000
83,185,000
80,082,000
61,451,000
13,302,000
33,894,000
-2,737,000
49,801,000
-65,694,000
41,971,000
33,069,000
-27,963,000
-49,147,000
-12,152,000
-27,636,000
36,691,000
-82,853,000
1,433,000
18,353,000
-25,349,000
-5,500,000
11,247,000
63,872,000
601,000
-80,771,000
19,863,000
77,637,000
9,949,000
-121,237,000
256,146,000
-313,956,000
-74,301,000
-60,953,000
-29,518,000
3,903,000
26,100,000
-64,262,000
12,981,000
99,550,000
4,447,000
-55,554,000
21,416,000
-20,604,000
168,720,000
-30,749,000
11,819,000
22,689,000
19,402,000
-6,610,000
4,462,000
144,117,000
-908,000
-24,617,000
10,048,000
-21,742,000
-21,782,000
-18,597,000
9,983,000
-14,274,000
13,169,000
-21,619,000
6,030,000
34,688,000
36,812,000
-8,586,000
10,604,000
6,940,000
-3,606,000
-13,071,000
38,849,000
-2,442,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.